Brighter World News  ➚

The new multivalent vaccine, manufactured for the clinical trial in MIRC’s Robert E. Fitzhenry Vector Laboratory, targets multiple viral proteins, both the spike protein on the surface and proteins inside the virus.

Three new Canada Research Chairs and two renewals awarded

MIRC’s Trainee of the Month

MIRC Doctoral trainees awarded CIHR’s Canada Graduate Scholarship

Type-I interferon stops immune system ‘going rogue’ during viral infections

MIRC’s Trainee of the Month

Recent publication from Allison Kennedy and Dawn Bowdish investigates immune dysregulation following mild cases of COVID-19

Brighter World News  ➚

MIRC Experts Charu Kaushic and Dawn Bowdish on why boosters are more important than ever

Brighter World News  ➚

Manali Mukherjee on long COVID

MIRC’s Trainee of the Month

Two Faculty professors honoured as Women of Distinction by YWCA

Brighter World News  ➚

MIRC’s Karen Mossman, leading virologist and McMaster’s vice-president, research, says the next major threat to human health could originate anywhere in the world.